Home > Insider Trading > Filing (0001209191-19-059089)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Biosciences Inc.	PCRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1288231	Phd P John Longenecker	C/O Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-12-02	872	$1.61	10,933	No	4	M	Direct
Common Stock	Acquisiton	2019-12-02	3,128	$1.61	14,061	No	4	M	Direct
Common Stock	Disposition	2019-12-02	1,300	$46.13	12,761	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-12-02	872	$0.00	872	$1.61
Common Stock	Stock Option (Right to Buy)	Disposition	2019-12-02	3,128	$0.00	3,128	$1.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-09-02	No	4	M	Direct
3,736		2020-09-02	No	4	M	Direct

Footnotes

The option vested as to 25% of the options on September 2, 2011 and vested as to the remaining options in successive equal monthly installments for the subsequent 36 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.
The option vested as to 75% of the options on September 2, 2010 and vested as to the remaining 25% of the options in successive equal monthly installments for the subsequent 12 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.